replagal
takeda pharmaceuticals international ag ireland branch - agalsidase alfa - fabry disease - andre alimentary tract and metabolism produkter, - replagal er indiceret til langsigtet enzymudskiftningsterapi hos patienter med en bekræftet diagnose af fabrys sygdom (a-galactosidase-a-mangel).
betahistindihydrochlorid "2care4" 16 mg tabletter
2care4 aps - betahistindihydrochlorid - tabletter - 16 mg
betahistindihydrochlorid "2care4" 8 mg tabletter
2care4 aps - betahistindihydrochlorid - tabletter - 8 mg
betaserc 16 mg tabletter
viatris aps - betahistindihydrochlorid - tabletter - 16 mg
betaserc 8 mg tabletter
viatris aps - betahistindihydrochlorid - tabletter - 8 mg
captopril/hydrochlorthiazid "ratiopharm" 25+12,5 mg tabletter
ratiopharm gmbh - captopril, hydrochlorthiazid - tabletter - 25+12,5 mg
captopril/hydrochlorthiazid "ratiopharm" 50+25 mg tabletter
ratiopharm gmbh - captopril, hydrochlorthiazid - tabletter - 50+25 mg
captopril "stada" 12,5 mg tabletter
stada arzneimittel ag - captopril - tabletter - 12,5 mg
captopril "stada" 25 mg tabletter
stada arzneimittel ag - captopril - tabletter - 25 mg
captopril "stada" 50 mg tabletter
stada arzneimittel ag - captopril - tabletter - 50 mg